Greg Bleck, Ph.D.

Global Head of R & D, Biologics, Catalent Biologics

Greg joined Catalent in 1998 as Director of Molecular Biology & Transgenics. He has a broad background in molecular biology, mammalian gene expression, cell culture and transgenic animals with 20 years experience with the organization.Greg has published over 55 research papers and co-authored three book chapters


    Day 1 Nov. 2

    Optimization of Titers and a Specific Enzyme Conversion Step to Generate Fully Processed Antibody in CHO Cells